Label-free proteomic analysis of breast cancer molecular subtypes

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4752-4772

  Panis, Carolina ^a,b   Pizzatti, Luciana ^a,c   Herrera, Ana Cristina ^d   Corrêa, Stephany ^a   Binato, Renata ^a   Abdelhay, Eliana ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

breast cancer; high throughput proteomics; subtypes

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; CYTOSKELETON PROTEIN; PROTEOME;

ADULT; APOPTOSIS; ARTICLE; BLOOD CLOTTING; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL CYCLE REGULATION; CELL LABELING; CONTROLLED STUDY; DNA REPAIR; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MIDDLE AGED; PROSPECTIVE STUDY; PROTEOMICS; TRIPLE NEGATIVE BREAST CANCER; TUMOR BIOPSY; TUMOR GROWTH; BREAST TUMOR; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SCREENING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CHROMATOGRAPHY, LIQUID; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MASS SPECTROMETRY; NEOPLASM INVASIVENESS; PROTEOME; PROTEOMICS;

EID: 84908892847     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500676x     Document Type: Article

References (49)

1. Ciriello, G.; Sinha, R.; Hoadley, K. A.; Jacobsen, A. S.; Reva, B.; Perou, C. M.; Sander, C.; Schultz, N. The molecular diversity of Luminal A breast tumors Breast Cancer Res. Treat. 2013, 141 (3) 409-420
2. Goldhirsch, A.; Winer, E. P.; Coates, A. S.; Gelber, R. D.; Piccart-Gebhart, M.; Thürlimann, B.; Senn, H. J. Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann. Oncol. 2013, 24 (9) 2206-2223
3. Nielsen, T. O.; Hsu, F. D.; Jensen, K.; Cheang, M.; Karaca, G.; Hu, Z.; Hernandez-Boussard, T.; Livasy, C.; Cowan, D.; Dressler, L.; Akslen, L. A.; Ragaz, J.; Gown, A. M.; Gilks, C. B.; van de Rijn, M.; Perou, C. M. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin. Cancer Res. 2004, 15;10 (16) 5367-5374
4. Panis, C.; Pizzatti, L.; Abdelhay, E. How can proteomics reach cancer biomarkers? Curr. Proteomics 2013, 10 (2) 136-149
5. Lam, S. W.; Jimenez, C. R.; Boven, E. Breast cancer classification by proteomic technologies: current state of knowledge Cancer Treat. Rev. 2014, 40 (1) 129-138
6. Panis, C.; Pizzatti, L.; Herrera, A. C.; Cecchini, R.; Abdelhay, E. Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution labelfree proteomics Cancer Lett. 2013, 330, 57-66
7. Liu, N. Q.; Braakman, R. B.; Stingl, C.; Luider, T. M.; Martens, J. W.; Foekens, J. A.; Umar, A. Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue J. Mammary Gland Biol. Neoplasia 2012, 17 (2) 155-164
8. Liu, N. Q.; Dekker, L. J.; Stingl, C.; Güzel, C.; De Marchi, T.; Martens, J. W.; Foekens, J. A.; Luider, T. M.; Umar, A. Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches J. Proteome Res. 2013, 12 (10) 4627-4641
9. Mbeunkui, F.; Goshe, M. B. Investigation of solubilization and digestion methods for microsomal membrane proteome analysis using data-independent LC-MSE Proteomics 2011, 11, 898-911
10. Liu, H.; Finch, J. W.; Luongo, J. A.; Li, G. Z.; Gebler, J. C. Development of an online two-dimensional nano-scale liquid chromatography/ mass spectrometry method for improved chromatographic performance and hydrophobic peptide recovery J. Chromatogr. 2006, 1135, 43-51
11. Silva, J. C.; Denny, R.; Dorschel, C. A.; Gorenstein, M.; Kass, I. J.; Li, G. Z.; McKenna, T.; Nold, M. J.; Richardson, K.; Young, P.; Geromanos, S. Quantitative proteomic analysis by accurate mass retention time pairs Anal. Chem. 2005, 77, 2187-2200
12. Pizzatti, L.; Panis, C.; Lemos, G.; Rocha, M.; Cecchini, R.; Souza, G. H.; Abdelhay, E. Label-free MSE proteomic analysis of chronic myeloid leukemia bone marrow plasma: disclosing new insights from therapy resistance Proteomics 2012, 12 (17) 2618-2631
13. Silva, J. C.; Gorenstein, M. V.; Li, G. Z.; Vissers, J. P.; Geromanos, S. J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition Mol. Cell. Proteomics 2006, 5, 144-156
14. Geromanos, S. J.; Hughes, C.; Golick, D.; Ciavarini, S.; Gorenstein, M. V.; Richardson, K.; Hoyes, J. B.; Vissers, J. P.; Langridge, J. I. Simulating and validating proteomics data and search results Proteomics 2011, 11 (6) 1189-1211
15. Li, G. Z.; Vissers, J. P.; Silva, J. C.; Golick, D.; Gorenstein, M. V.; Geromanos, S. J. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures Proteomics 2009, 9 (6) 1696-1719
16. Brunet, A.; Kanai, F.; Stehn, J.; Xu, J.; Sarbassova, D.; Frangioni, J. V.; Dalal, S. N.; DeCaprio, J. A.; Greenberg, M. E.; Yaffe, M. B. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport J. Cell Biol. 2002, 156 (5) 817-828
17. Mencalha, A.; Victorino, V. J.; Cecchini, R.; Panis, C. Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics Anticancer Res. 2014, 34 (3) 1127-1140
18. Rutkowski, M. J.; Sughrue, M. E.; Kane, A. J.; Mills, S. A.; Parsa, A. T. Cancer and the complement cascade Mol. Cancer Res. 2010, 8 (11) 1453-1465
19. Lima, L. G.; Monteiro, R. Q. Activation of blood coagulation in cancer: implications for tumour progression Biosci. Rep. 2013, 4;33 (5) 701-710
20. Danckwardt, S.; Hentze, M. W.; Kulozik, A. E. Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond J. Mol. Med. 2013, 91 (11) 1257-71
21. Panis, C.; Herrera, A. C.; Victorino, V. J.; Aranome, A. M.; Cecchini, R. Screening of circulating TGF-β levels and its clinicopathological significance in human breast cancer Anticancer Res. 2013, 33 (2) 737-742
22. Román-Pérez, E.; Casbas-Hernández, P.; Pirone, J. R.; Rein, J.; Carey, L. A.; Lubet, R. A.; Mani, S. A.; Amos, K. D.; Troester, M. A. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients Breast Cancer Res. 2012, 14 (2) R51
23. Goldhirsch, A.; Winer, E. P.; Coates, A. S.; Gelber, R. D.; Piccart-Gebhart, M.; Thürlimann, B.; Senn, H. J. Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann. Oncol. 2013, 24 (9) 2206-2223
24. Giretti, M. S.; Montt Guevara, M. M.; Cecchi, E.; Mannella, P.; Palla, G.; Spina, S.; Bernacchi, G.; Di Bello, S.; Genazzani, A. R.; Genazzani, A. D.; Simoncini, T. Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton Front. Endocrinol.. 2014, 26 (5) 80
25. Niu, Y.; Wang, S.; Liu, T.; Zhang, T.; Wei, X.; Wang, Y.; Jiang, L. Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma Pathol., Res. Pract. 2013, 209 (4) 221-227
26. Yu, X.; Zech, T.; McDonald, L.; Gonzalez, E. G.; Li, A.; Macpherson, I.; Schwarz, J. P.; Spence, H.; Futó, K.; Timpson, P.; Nixon, C.; Ma, Y.; Anton, I. M.; Visegrády, B.; Insall, R. H.; Oien, K.; Blyth, K.; Norman, J. C.; Machesky, L. M. N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopods J. Cell Biol. 2012, 199 (3) 527-544
27. Sneh, A.; Deol, Y. S.; Ganju, A.; Shilo, K.; Rosol, T. J.; Nasser, M. W.; Ganju, R. K. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling Breast Cancer Res. Treat. 2013, 138 (3) 727-739
28. Wang, D.; Huang, J.; Hu, Zhi. RNA Helicase DDX5 Regulates MicroRNA Expression and Contributes to Cytoskeletal Reorganization in Basal Breast Cancer Cells Mol. Cell. Proteomics. 2012, 11 (2) M111.011932
29. Niemiec, J. A.; Adamczyk, A.; Małecki, K.; Majchrzyk, K.; Rys̈, J. Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/P-cadherin, and MMP-2 expression in early-stage invasive ductal breast cancer Appl. Immunohistochem. Mol. Morphol. 2012, 20 (6) 550-560
30. Turashvili, G.; McKinney, S. E.; Goktepe, O.; Leung, S. C.; Huntsman, D. G.; Gelmon, K. A.; Los, G.; Rejto, P. A.; Aparicio, S. A. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer Mod. Pathol. 2011, 24 (1) 64-81
31. Crapoulet, N.; OBrien, P.; Ouellette, R. J.; Robichaud, G. A. Coordinated expression of Pax-5 and FAK1 in metastasis Anticancer Agents Med. Chem. 2011, 11 (7) 643-649
32. Biswas, S.; Sengupta, S.; Roy Chowdhury, S.; Jana, S.; Mandal, G.; Mandal, P. K.; Saha, N.; Malhotra, V.; Gupta, A.; Kuprash, D. V.; Bhattacharyya, A. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis Breast Cancer Res. Treat. 2014, 143 (2) 265-276
33. Nishimiya, H.; Kosaka, Y.; Yamashita, K.; Minatani, N.; Kikuchi, M.; Ema, A.; Nakamura, K.; Waraya, M.; Sengoku, N.; Tanino, H.; Kuranami, M.; Watanabe, M. Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up Anticancer Res. 2014, 34 (1) 259-268
34. Jacot, W.; Fiche, M.; Zaman, K.; Wolfer, A.; Lamy, P. J. The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond Biochim. Biophys. Acta 2013, 1836 (1) 146-157
35. Santarpia, L.; Iwamoto, T.; Di Leo, A.; Hayashi, N.; Bottai, G.; Stampfer, M.; André, F.; Turner, N. C.; Symmans, W. F.; Hortobágyi, G. N.; Pusztai, L.; Bianchini, G. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes Oncologist 2013, 18 (10) 1063-1073
36. Rutkowski, M. J.; Sughrue, M. E.; Kane, A. J.; Mills, S. A.; Parsa, A. T. Cancer and the Complement Cascade Mol. Cancer Res. 2010, 8, 1453-1465
37. Nielsen, V. G.; Ley, M. L.; Waer, A. L.; Alger, P. W.; Matika, R. W.; Steinbrenner, E. B. Plasmatic hypercoagulation in patients with breast cancer: role of heme oxygenase-1 Blood Coagulation Fibrinolysis 2013, 24 (8) 809-813
38. Ferroni, P.; Roselli, M.; Portarena, I.; Formica, V.; Riondino, S.L. A.; Farina, F.; Costarelli, L.; Melino, A.; Massimiani, G.; Cavaliere, F.; Palmirotta, R.; Guadagni, F. Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer-relationship with clinical outcome Anticancer Res. 2014, 34 (3) 1153-1161
39. Marchetti, M.; Russo, L.; Balducci, D.; Falanga, A. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells Thromb. Res. 2011, 128 (4) 368-374
40. Samarajeewa, N. U.; Docanto, M. M.; Simpson, E. R.; Brown, K. A. CREB-regulated transcription co-activator family stimulates promoter II-driven aromatase expression in preadipocytes Horm. Cancer 2013, 4 (4) 233-241
41. Knutson, T. P.; Daniel, A. R.; Fan, D.; Silverstein, K. A.; Covington, K. R.; Fuqua, S. A.; Lange, C. A. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression Breast Cancer Res. 2012, 14;14 (3) R95
42. Alberti, C.; Pinciroli, P.; Valeri, B.; Ferri, R.; Ditto, A.; Umezawa, K.; Sensi, M.; Canevari, S.; Tomassetti, A. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer Oncogene 2012, 13;31 (37) 4139-4149
43. Ferguson, I. D.; Griffin, P.; Michel, J.; Kietz, D.; Rosenkranz, M.; Vallejo, A. N. A113: TCR-independent Activation of T-cells Through CD31 Triggering as an Etiology of Cytokine Production in Juvenile Idiopathic Arthritis Arthritis Rheumatol. 2014, 66 (Suppl 11) S150
44. Bertucci, F.; Finetti, P.; Cervera, N.; Charafe-Jauffret, E.; Buttarelli, M.; Jacquemier, J.; Chaffanet, M.; Maraninchi, D.; Viens, P.; Birnbaum, D. How different are luminal A and basal breast cancers? Int. J. Cancer. 2009, 15;124 (6) 1338-1348
45. Martín-Pérez, R.; Palacios, C.; Yerbes, R.; Cano-González, A.; Iglesias-Serret, D.; Gil, J.; Reginato, M. J.; López-Rivas, A. Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway Cancer Res. 2014, 15;74 (6) 1766-1777
46. Cheng, Y.; Holloway, M. P.; Nguyen, K.; McCauley, D.; Landesman, Y.; Kauffman, M. G.; Shacham, S.; Altura, R. A. XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer Mol. Cancer Ther. 2014, 13 (3) 675-686
47. Horiuchi, D.; Kusdra, L.; Huskey, N. E.; Chandriani, S.; Lenburg, M. E.; Gonzalez-Angulo, A. M.; Creasman, K. J.; Bazarov, A. V.; Smyth, J. W.; Davis, S. E.; Yaswen, P.; Mills, G. B.; Esserman, L. J.; Goga, A. MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition J. Exp. Med. 2012, 9;209 (4) 679-696
48. Ren, J.; Jin, F.; Yu, Z.; Zhao, L.; Wang, L.; Bai, X.; Zhao, H.; Yao, W.; Mi, X.; Wang, E.; Olopade, O. I.; Wei, M. MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency Tumour Biol. 2013, 34 (6) 3945-3958
49. Pereira, C. B.; Leal, M. F.; de Souza, C. R.; Montenegro, R. C.; Rey, J. A.; Carvalho, A. A.; Assumpção, P. P.; Khayat, A. S.; Pinto, G. R.; Demachki, S.; de Arruda Cardoso Smith, M.; Burbano, R.R. Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy PLoS One 2013, 8 (3) e60576